Our Insights

Ahead of the Curve®

Jun 9, 2022

Forward Progress: ESG Primer on Clinical Trial Diversity

Apr 29, 2022

Investment Banking First Quarter 2022

Ahead of the Curve®

Mar 11, 2022

Synthetic Biology 2.0: High-Growth Vertical Disrupting Many End Markets

Feb 16, 2022

2021 Investment Banking Year in Review

Ahead of the Curve®

Nov 16, 2021

Trials and Triumphs of Gene Editing: A Compendium

Ahead of the Curve®

Oct 15, 2021

Fueling the Future: A Primer on Cell and Gene Therapy Tools

Oct 11, 2021

Proteomics Tools 2.0: Evaluating Next-Generation Solutions

Ahead of the Curve®

Sep 18, 2020

Liquid Biopsy: Early Detection of a Huge Investment Opportunity

Jun 22, 2020

FutureHealth Podcast Series

Ahead of the Curve®

Apr 21, 2020

The Role of Diagnostics in COVID-19 “Return to Normalcy”

Apr 14, 2020

The COVID-19 Testing Environment & the Role Testing will Play in “Return to Normalcy”

Nov 10, 2014

A Closer Look at Liquid Biopsy: Background, Key Players & Market Opportunity